Scynexis (SCYX) Return on Invested Capital (2019 - 2023)

Scynexis' (SCYX) quarterly Return on Invested Capital came in at 0.02% in Q4 2023, up 3.79% on a QoQ basis from 0.02% in Q3 2023.

Scynexis (SCYX) Return on Invested Capital (2019 - 2023) Analysis & Trends

Scynexis (SCYX) has 2 years of Return on Invested Capital data on file, last reported at 0.02% in Q4 2023.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	ROIC (Qtr)
1	Haleon	43.83 Bn	42.86 Bn	-	-
2	Teva Pharmaceutical Industries	42.87 Bn	39.22 Bn	2.15 Bn	0.00%
3	Zoetis	31.41 Bn	29.73 Bn	1.05 Bn	-
4	Takeda Pharmaceutical	28.55 Bn	22.75 Bn	5.10 Bn	0.00%
5	United Therapeutics	22.08 Bn	19.42 Bn	683.80 Mn	-
6	Viatris	18.73 Bn	17.84 Bn	1.46 Bn	0.00%
7	Neurocrine Biosciences	15.44 Bn	15.05 Bn	935.80 Mn	-
8	Elanco Animal Health	11.75 Bn	11.22 Bn	798.00 Mn	0.03%
9	Dr Reddys Laboratories	10.11 Bn	9.94 Bn	-	-
10	Scynexis	61.37 Mn	-53.33 Mn	-	-

Download Data